top of page

BB Binomika Customer Forum 2026: Ministry of Health Recognizes Equilab International for Contributing in Healthcare and Clinical Trial Ecosystem in Indonesia

9 hours ago
2 min read

Jakarta, 3 November 2026 – Balai Besar Biomedis dan Genomika Kesehatan (BB Binomika) or also known as The Center for Biomedical and Genome Health in the Ministry of Health, organized the BB Binomika Customer Forum 2026. The event was held at Manhattan Hotel Jakarta, the forum brought together healthcare professionals, industry partners, laboratory representatives, and other stakeholders to discuss service improvements, strengthen collaboration, and explore opportunities for future partnerships. Equilab International participated in the forum as one of the speaker and exhibitors.


Equilab International with Prof. Dr. Dante Saksono

Carrying the theme “Listen. Connect. Improve.”, the forum also marked the launch of BB Binomika’s new services. It provided a platform for BB Binomika to gather customer feedback, understand service needs, and identify opportunities to improve healthcare and laboratory services across Indonesia. The event was opened by Prof. Dr. Dante Saksono Harbuwono, Sp.PD-KEMD, Ph.D., Vice Minister of Health of the Republic of Indonesia. “Improving healthcare services is essential to enhancing service experiences and meeting the expectations of the Indonesian public and healthcare industry,” he stated during his opening remarks.


Indri Rooslamiati, M.Sc., as the Head of BB Binomika

Indri Rooslamiati, M.Sc., Head of BB Binomika, emphasized the importance of listening to customer feedback, connecting with stakeholders through collaboration, and improving services based on their input. She also highlighted the need to address service-related challenges, including timelines and regulations within the Ministry of Health, which are relevant to the development of clinical trials in Indonesia.


Panelists Session at BB Binomika Customer Forum 2026

The forum further featured discussions on service development, customer experiences, and opportunities to strengthen collaboration across clinical trials, healthcare digitalization efforts, and biomedical services to be provided by BB Binomika. Lucia Rat Handayani, S.Si., representing Equilab as Head of Clinical Operations Equilab International, expressed her appreciation for BB Binomika’s support. “We appreciate BB Binomika’s ongoing collaboration in supporting the development of Indonesia’s clinical research ecosystem. Continued cooperation in areas such as Material Transfer Agreements (MTA), regulatory processes, and study feasibility is essential to supporting the advancement of clinical trials in Indonesia,” she stated.


Lucia Rat Handayani, S.Si., as the Head of Clinical Operations Equilab International with Indri Rooslamiati, M.Sc., as the Head of BB Binomika

Equilab International, as a leading CRO in Indonesia, reaffirms its commitment to supporting BB Binomika and key healthcare stakeholders in future strategic collaborations. Through continuous synergy and shared technical expertise, this partnership aims to advance healthcare services while strengthening the nation’s clinical research ecosystem. Ultimately, these joint efforts will lay a solid foundation for a more resilient, integrated, and self-reliant health landscape in Indonesia.



 
 
bottom of page